Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes

Prema B. Rapuri, J. Christopher Gallagher, H. Karimi Kinyamu, Kay L. Ryschon

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Background: The role of caffeine as a risk factor for bone loss is controversial. Objective: Our goals were 1) to compare in both a cross-sectional study and a 3-y longitudinal study the bone mineral density (BMD) of postmenopausal women consuming high or low amounts of caffeine and 2) to study the interaction between caffeine intake, vitamin D receptor (VDR) polymorphism, and BMD in the longitudinal study. Design: The results are derived from cross-sectional measurements of BMD in 489 elderly women (aged 65-77 y) and from longitudinal measurements made in 96 of these women who were treated with a placebo for 3 y. Changes in BMD were adjusted for confounding factors and were compared between groups with either low (≤ 300 mg/d) or high (> 300 mg/d) caffeine intakes and between the VDR genotype subgroups of the low- and high-caffeine groups. Results: Women with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes (-1.90 ± 0.97% compared with 1.19 ± 1.08%; P = 0.038). When the data were analyzed according to VDR genotype and caffeine intake, women with the tt genotype had significantly (P = 0.054) higher rates of bone loss at the spine (-8.14 ± 2.62%) than did women with the TT genotype (-0.34 ± 1.42%) when their caffeine intake was > 300 mg/d. Conclusions: Intakes of caffeine in amounts > 300 mg/d (≈514 g, or 18 oz, brewed coffee) accelerate bone loss at the spine in elderly postmenopausal women. Furthermore, women with the tt genetic variant of VDR appear to be at a greater risk for this deleterious effect of caffeine on bone.

Original languageEnglish
Pages (from-to)694-700
Number of pages7
JournalAmerican Journal of Clinical Nutrition
Volume74
Issue number5
StatePublished - 2001

Fingerprint

Calcitriol Receptors
caffeine
vitamin D
Caffeine
Genotype
bones
Bone and Bones
receptors
genotype
bone density
Bone Density
spine (bones)
Spine
longitudinal studies
Longitudinal Studies
coffee (beverage)
Coffee
cross-sectional studies
placebos
risk factors

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Food Science

Cite this

Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. / Rapuri, Prema B.; Gallagher, J. Christopher; Kinyamu, H. Karimi; Ryschon, Kay L.

In: American Journal of Clinical Nutrition, Vol. 74, No. 5, 2001, p. 694-700.

Research output: Contribution to journalArticle

@article{ce4f46bee33c490fad83bfe450989dd6,
title = "Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes",
abstract = "Background: The role of caffeine as a risk factor for bone loss is controversial. Objective: Our goals were 1) to compare in both a cross-sectional study and a 3-y longitudinal study the bone mineral density (BMD) of postmenopausal women consuming high or low amounts of caffeine and 2) to study the interaction between caffeine intake, vitamin D receptor (VDR) polymorphism, and BMD in the longitudinal study. Design: The results are derived from cross-sectional measurements of BMD in 489 elderly women (aged 65-77 y) and from longitudinal measurements made in 96 of these women who were treated with a placebo for 3 y. Changes in BMD were adjusted for confounding factors and were compared between groups with either low (≤ 300 mg/d) or high (> 300 mg/d) caffeine intakes and between the VDR genotype subgroups of the low- and high-caffeine groups. Results: Women with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes (-1.90 ± 0.97{\%} compared with 1.19 ± 1.08{\%}; P = 0.038). When the data were analyzed according to VDR genotype and caffeine intake, women with the tt genotype had significantly (P = 0.054) higher rates of bone loss at the spine (-8.14 ± 2.62{\%}) than did women with the TT genotype (-0.34 ± 1.42{\%}) when their caffeine intake was > 300 mg/d. Conclusions: Intakes of caffeine in amounts > 300 mg/d (≈514 g, or 18 oz, brewed coffee) accelerate bone loss at the spine in elderly postmenopausal women. Furthermore, women with the tt genetic variant of VDR appear to be at a greater risk for this deleterious effect of caffeine on bone.",
author = "Rapuri, {Prema B.} and Gallagher, {J. Christopher} and Kinyamu, {H. Karimi} and Ryschon, {Kay L.}",
year = "2001",
language = "English",
volume = "74",
pages = "694--700",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes

AU - Rapuri, Prema B.

AU - Gallagher, J. Christopher

AU - Kinyamu, H. Karimi

AU - Ryschon, Kay L.

PY - 2001

Y1 - 2001

N2 - Background: The role of caffeine as a risk factor for bone loss is controversial. Objective: Our goals were 1) to compare in both a cross-sectional study and a 3-y longitudinal study the bone mineral density (BMD) of postmenopausal women consuming high or low amounts of caffeine and 2) to study the interaction between caffeine intake, vitamin D receptor (VDR) polymorphism, and BMD in the longitudinal study. Design: The results are derived from cross-sectional measurements of BMD in 489 elderly women (aged 65-77 y) and from longitudinal measurements made in 96 of these women who were treated with a placebo for 3 y. Changes in BMD were adjusted for confounding factors and were compared between groups with either low (≤ 300 mg/d) or high (> 300 mg/d) caffeine intakes and between the VDR genotype subgroups of the low- and high-caffeine groups. Results: Women with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes (-1.90 ± 0.97% compared with 1.19 ± 1.08%; P = 0.038). When the data were analyzed according to VDR genotype and caffeine intake, women with the tt genotype had significantly (P = 0.054) higher rates of bone loss at the spine (-8.14 ± 2.62%) than did women with the TT genotype (-0.34 ± 1.42%) when their caffeine intake was > 300 mg/d. Conclusions: Intakes of caffeine in amounts > 300 mg/d (≈514 g, or 18 oz, brewed coffee) accelerate bone loss at the spine in elderly postmenopausal women. Furthermore, women with the tt genetic variant of VDR appear to be at a greater risk for this deleterious effect of caffeine on bone.

AB - Background: The role of caffeine as a risk factor for bone loss is controversial. Objective: Our goals were 1) to compare in both a cross-sectional study and a 3-y longitudinal study the bone mineral density (BMD) of postmenopausal women consuming high or low amounts of caffeine and 2) to study the interaction between caffeine intake, vitamin D receptor (VDR) polymorphism, and BMD in the longitudinal study. Design: The results are derived from cross-sectional measurements of BMD in 489 elderly women (aged 65-77 y) and from longitudinal measurements made in 96 of these women who were treated with a placebo for 3 y. Changes in BMD were adjusted for confounding factors and were compared between groups with either low (≤ 300 mg/d) or high (> 300 mg/d) caffeine intakes and between the VDR genotype subgroups of the low- and high-caffeine groups. Results: Women with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes (-1.90 ± 0.97% compared with 1.19 ± 1.08%; P = 0.038). When the data were analyzed according to VDR genotype and caffeine intake, women with the tt genotype had significantly (P = 0.054) higher rates of bone loss at the spine (-8.14 ± 2.62%) than did women with the TT genotype (-0.34 ± 1.42%) when their caffeine intake was > 300 mg/d. Conclusions: Intakes of caffeine in amounts > 300 mg/d (≈514 g, or 18 oz, brewed coffee) accelerate bone loss at the spine in elderly postmenopausal women. Furthermore, women with the tt genetic variant of VDR appear to be at a greater risk for this deleterious effect of caffeine on bone.

UR - http://www.scopus.com/inward/record.url?scp=0034749566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034749566&partnerID=8YFLogxK

M3 - Article

C2 - 11684540

AN - SCOPUS:0034749566

VL - 74

SP - 694

EP - 700

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 5

ER -